← Leaderboards
Joel William Blanchard
Massachusetts Institute Of Technology
$5,247,625
Attributed
$9,221,271
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,221,271 · 4
By mechanism
UH3$3,475,569 · 1
R01$3,260,802 · 2
UG3$2,484,900 · 1
Top collaborators
- Manolis Kellis5 shared
- Li-Huei Tsai5 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Patrick S Doyle$2,934,658
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCell TypeBrainGeneticPathologicMolecularCellsTissuesTechnologyTranscriptomicsResponseSingle-Cell Rna SequencingInsightAffectPathologyNeuronsS DiseaseAutopsyNovel StrategiesReporterCell LineFunctional DisorderImageAstrocytes
Grant awards (13)
Investigating the combined role of APOE4 and ketogenic diets in Alzheimer's disease$695,802
R01 · FY2025 · AG · contact PI
Investigating the combined role of APOE4 and ketogenic diets in Alzheimer's disease$714,224
R01 · FY2024 · AG · contact PI
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons$386,375
R01 · FY2024 · NS · contact PI
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons$134,713
R01 · FY2024 · NS · contact PI
Construction of an Integrated Immune - Vascular Brain - Chip as a Platform for the Study, Drug Screening, and Treatments of Alzheimer's Disease$1,158,523
UH3 · FY2023 · NS
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons$398,325
R01 · FY2023 · NS · contact PI
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons$134,713
R01 · FY2023 · NS · contact PI
Construction of an Integrated Immune-Vascular Brain - Chip as a Platform for the Study, Drug Screening, and Treatments of Alzheimer's Disease$1,158,523
UH3 · FY2022 · NS
Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons$398,325
R01 · FY2022 · NS · contact PI
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease$1,158,523
UH3 · FY2021 · NS
Understanding cell-type vulnerability and oxidative stress pathology in Parkinson's Disease using isogenic human dopaminergic neurons$398,325
R01 · FY2021 · NS · contact PI
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease$225,900
UG3 · FY2020 · NS
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease$2,259,000
UG3 · FY2019 · NS